IVF in Cattle Breeding: High Gains or a High Gamble?

A summary of the panel session with Rob Simmons, Chris Bailey, Keith Gue (Dairy Farmer) and Ben Lewis (Beef Farmer). Summary provided by Rob Simmons and Chris Bailey, Veterinary Surgeons, Paragon Vet

The landscape of cattle reproduction is undergoing a fundamental shift. At the recent British Cattle Breeders Club (BCBC) conference, a panel of veterinary surgeons and active breeders gathered to dissect the real-world application of advanced reproductive technologies. The session, titled “IVF: Big Gains or Big Gamble?”, provided a data-driven look at how In Vitro Fertilization (IVF) and Multiple Ovulation Embryo Transfer (MOET) are being utilized to accelerate genetic gain in 2026.

The Global Context: A Tipping Point

Rob Simmons, Lead Vet in Advanced Breeding at Paragon Vets, set the stage by revealing that IVF has now definitively surpassed traditional flushing (MOET) on a global scale. As of 2024, data showed over 2 million IVF embryos produced annually, compared to fewer than 300,000 MOET embryos.

This global surge is driven by the efficiency of the Ovum Pick-Up (OPU) process. In the UK, the technology has evolved from a rescue tool for sub-fertile cows into a primary strategy for multiplying elite genetics from young, high-genomic heifers as early as 7 months of age.

Technical Deep Dive: IVF vs. MOET

Understanding the choice between these two paths requires a look at the operational trade-offs highlighted during the conference.

MOET (Multiple Ovulation Embryo Transfer)

MOET remains the tried and tested method, involving the superovulation of a donor through approximately 8 injections of FSH over 4 days, followed by three rounds of Artificial Insemination (AI). Embryos are “flushed” from the uterus seven days later.

• The Advantage: MOET typically yields embryos with higher pregnancy rates and lower rates of pregnancy loss compared to IVF.
• The Risk: It is an all or nothing game. A donor might fail to respond to the hormones, resulting in a “zero flush” despite the significant investment in semen and vet time.

OPU-IVF (In Vitro Fertilization)

IVF involves collecting oocytes directly from the ovaries using an ultrasound-guided needle (OPU). These are fertilized in a laboratory and grown for seven days before being transferred or frozen.

• The Advantage: Efficiency is the primary draw. One straw of semen can fertilize oocytes from up to three donors, making elite or expensive sires far more accessible. Crucially, IVF can be performed on pregnant donors (up to roughly 4 months) and young heifers, significantly shortening the generational interval. It also produces a larger number of embryos over time than MOET.
• The Risk: Historically, IVF was associated with “large calf syndrome,” though panellists noted these instances are now very rare with improved lab media. However, pregnancy losses remain roughly 5-10% higher than with MOET.

The Breeder’s Perspective: Beef vs. Dairy

The conference highlighted distinct motivations for adopting these technologies across different sectors.

The Dairy Case: Rapid Genomic Progress

Christopher Bailey, a fourth-generation dairy farmer and vet, shared a case study of a high-genomic heifer ranking in the UK’s top 30 for Profitable Lifetime Index (PLI). By utilizing embryo transfer, he produced a small cohort of calves that averaged 200 PLI points higher than his standard herd replacements. This leap effectively bypassed years of conventional breeding cycles.

The Beef Case: Scaling Maternal Lines

Ben Lewis of Haven Herefords demonstrated that for beef producers, the financial incentive is tied to the multiplication of elite maternal lines. His data showed a net gain of approximately £530 per live calf born via IVF compared to those from the bottom 15% of the herd. He emphasized that IVF allows breeders to “bank” the best genetics while keeping the donor cow in her natural production cycle.

Economic Reality: When Does it Pay?

Keith Gue of Huddlestone Farmers Ltd. offered a sobering perspective on the ROI. He noted that as the genetic gap between the top tier and the herd average narrows, the high cost of IVF becomes harder to justify. Keith reported that his operation moved back toward MOET after finding IVF results inconsistent, achieving a cost per live calf of roughly £195 for MOET compared to higher figures for external IVF services.

The Road Ahead: 2026 and Beyond

The session concluded with a warning against genetic narrowing. As breeders chase the top 1% of PLI or EPD lists, the risk of inbreeding rises. Panellists urged the industry to use IVF not just for speed, but to strategically maintain genetic diversity by identifying and multiplying distinct, high-performing lines rather than just the “bull of the month”.